The association between the VNTR polymorphism and neuropsychiatric disorders has been studied, but their relationship is still unclear. Here we identified a novel polymorphism in the 3Ј-UTR of the DAT1 gene, G2319A, and a significant association between the polymorphism and alcoholism was observed in both genotypic and allelic frequencies (P = 0.040 and 0.019, extended Fisher's exact test, respectively). There was a significant gene dose effect on the risk for alcoholism associated with the 2319-A allele ( 2 = 6.16, df = 2, P = 0.046, linearity tendency test: Cochranq-Armitage analysis). Moreover, in the haplotype analysis with G2319A-and VNTR-polymorphisms, a positive gene dose efffect on the risk with the A10 allele (P = 0.044, linearity tendency test) and a negative gene dose effect with the G10 allele (P = 0.010, linearity tendency test) for alcoholism were significantly detected. Odds ratio for alcoholism with the A10 and G10 alleles were 1.76 (1.12-2.76) and 0.53 (0.32-0.79), respectively. These results indicate that the DAT1 gene may confer vulnerability to alcoholism.
Introduction
Both addictive substances disorder and schizophrenic disorder are complex behavioral disorders likely to represent interactions between genetic and environmental factors. 1, 2 Family, twin, and adoption studies have indicated substantial heritability in the etiology of alcoholism 3 and schizophrenia, 1, [4] [5] [6] but the molecular mechanisms of pathogenesis are still poorly understood. Dopaminergic brain systems play important roles in drug reward and reinforcement, therefore attention is focused on genes expressed in these circuits as candidates contributing to alcoholism. Psychostimulants, such as amphetamine, can activate the dopaminergic system and arouse schizophrenia-like positive symptoms, and the antipsychotic drugs in blocking dopamine receptors inhibit schizophrenic positive symptoms. Our group reported that the polymorphism of dopamine D2 receptor was significantly associated with alcoholism, 7 and with schizophrenia, 8 but its association is still unclear. 9 Assessments of Correspondence: Dr A Sano, Dept of Neuropsychiatry, Ehime University School of Medicine, Shigenobu, Onsen-gun, Ehime 791-0295, Japan. E-mail: sano@m.ehime-u.ac.jp Received 21 January 1999; revised and accepted 25 March 1999 dopaminergic turnover and dopamine receptor binding in schizophrenic patients suggest that dopaminergic hyperactivity causes schizophrenia and related disorders. The human dopamine transporter (DAT1) is a member of the 12-transmembrane domain sodium and chloride-dependent neurotransmitter transporter family with very high affinity and substrate specificity. 10 Reuptake of dopamine into presynaptic neurons by means of DAT1 is believed to be the primary mechanism for termination of dopaminergic neurotransmission. Studies using single photon emission computed tomography revealed that the highest concentrations of DAT1 are found in the basal ganglia, and striatal density was shown to be markedly lower in non-violent alcoholics. 11 The 40-bp variable number of tandem repeats (VNTR) polymorphism was found in the 3Ј-untranslated region of the DAT1 gene. 11, 12 Several groups reported the association of the VNTR-polymorphism in the 3Ј-untranslated region of the DAT1 gene and alcoholism with low activity of aldehyde dehydrogenase II, 13 and with alcohol withdrawal seizures or delirium. 14 The linkage and association studies between the VNTR polymorphism and schizophrenic disorders have been performed, but the relationship between the DAT1 gene and these disorders is still unclear. [14] [15] [16] [17] [18] In this study, we identified a novel polymorphic site in the 3Ј-untranslated region of the DAT1 gene. We examined the novel and the VNTR polymorphisms to study the association of the DAT1 gene with alcoholism or schizophrenia.
Materials and methods

Subjects
Groups of Japanese subjects were studied with alcoholism (n = 124, 118 men and six women, with a mean ± SEM age of 51.7 ± 0.9 years) and schizophrenia (n = 72, 23 men and 49 women, 36.2 ± 12.6 years) compared to mentally healthy controls (n = 107, 55 men and 52 women, 48.8 ± 1.6 years). The alcoholic patients were recruited in four local hospitals in Japan and had been diagnosed by two psychiatrists according to the criteria from Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) (APA 1987) for alcohol dependence (code 303.90) and Criteria for the Diagnosis of Alcoholism by the Criteria Committee, National Council on Alcoholism (NCA) (NCA 1972) . The alcoholic patients with psychoses other than those associated with alcohol use were excluded. Schizophrenic patients were recruited at Ehime University Hospital in Japan and had been diagnosed by two psychiatrists according to the criteria of DSM-III-R for schizophrenia (codes 295.1x, 295.2x, 295.3x, 295,6x, and 295.9x). A control group with good social, occupational, or recreational activities was recruited at Ehime University Hospital and they did not meet the criteria for alcoholism or schizophrenia. All patients (or family members) and controls gave written informed consent. Genomic DNA was prepared from peripheral blood leukocytes according to standard method.
Sequencing studies
Sequencing reactions were carried out on PCR-amplified samples of human DAT1 gene. For sequence analysis, PCR products were cloned in T-vectors with transformed JM 109 E. coli (Novagen, WI, USA). Single colonies were lysated in 50 l H 2 O by boiling for 5 min. The lysates were used as template for PCR with insert specific primer pairs. After a mini preparation of colonies with insert, analyses were performed on both strands of double-stranded PCR products with universal primers, T7 and U19, using a commercial kit (Bca BEST TM Dideoxy Sequencing Kit, Takara, Tokyo, Japan) according to the manufacturer's instructions.
PCR-RFLP, VNTR analysis and haplotype analysis
Genotyping of the DNA sequence variants was performed by means of PCR-based RFLP assays ( Figure 1 ). PCR amplification of the 3Ј-UTR of the DAT1 gene was accomplished with the primers designed to amplify for the purpose of RFLP and haplotype analysis. Primer sequences were given 5Ј-3Ј, forward and reverse. The predicted sizes, in bp, of the amplified fragments are bracketed after each reverse primer sequence; for sequence and haplotype analysis, 3Ј-UTR-F; AGAC-GAAGACCCCAGGAAGT, 3Ј-UTR-R: CCATTCGCAAA-CATAAAAAC (the size is different from the length of VNTR; it is 1217 bp if the VNTR is 10-repeat), for the G2319A-polymorphism, 3Ј-1F: CCGTGTCTTGTGTT GCTGTA, 3Ј-1R: ACGGGGATTCTCAGCA GGTG (217 bp); for the VNTR polymorphism, 3Ј-VNTR-F: GCGT GTACTACCCCAGAACG, 3Ј-VNTR-R: GCCAGGCA-GAGTGTTGGTCT (the size is different from the length of VNTR; it is 314 bp if the VNTR is 10-repeat). Reactions were carried out in a total volume of 12.5 l containing 1 × PCR buffer (Takara), 100 ng of genomic DNA, primers at 0.2 M, dNTPs at 0.2 mM and 0.5 U of Taq polymerase (Takara). MgCl 2 was added to make a final concentration of 1.5 mM. Each reaction began with a single denaturation step of 94°C for 1 min, which was followed by 35 cycles of 30 s at 94°C, 30 s at either 54°C (3Ј-UTR), 57°C (3Ј-1), 61°C (3Ј-VNTR), and 30 s at 72°C. Reactions were completed with one step of 5 min at 72°C. The sequence change of the 2319th nucleotide of the DAT1 gene from G to A excluded a restriction site for endonuclease Msp I, resulting in an RFLP. An aliquot of PCR product was incubated with Msp I according to the manufacturer's recommendations (New England BioLabs, Schwalbach, Germany). Fragments were separated in a 3% NuSieve gel and visualized by ethidium bromide. The VNTR analysis of the DAT1 gene was performed by the method of Sano et al. 12 The haplotype analyses of G2319A and VNTR in the subject with the genotypes different in the repeat-number of the VNTR polymorphism were done after extraction of the PCR products from the agarose gel which separates the alleles different in the repeat-number of the VNTR polymorphism ( Figure 1 ).
Statistical analysis
Departure from Hardy-Weinberg equilibrium was tested using 2 goodness-of-fit tests. Statistical significance of differenes between allele distributions was assessed using 2 tests and Fisher's exact tests. The linearity tendency test was performed by Cochranq-Armitage analysis. The statistical analysis on linkage disequilibrium was performed using 2 tests and Fisher's exact tests.
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Results
We analyzed the sequences of 3Ј-untranslated region (3Ј-UTR) of the DAT1 gene from several persons' genomic DNA, and we found a single nucleotide substitution from the previously reported sequence 10 in a certain clone, which corresponds to a G to A transition at position 2319 in DAT cDNA (accession number M95167). This substitution from G to A removes an Msp I restriction site (Figure 2 ). Using PCR-RFLP analysis with Msp I, G2319A was demonstrated to be a polymorphism in the Japanese population. Allele frequencies estimated in the Japanese controls were 0.83 for 2319-G and 0.17 for 2319-A allele, respectively (n = 107). Hardy-Weinberg equilibrium was confirmed ( 2 = 0.56, df = 1). The genotypic and allelic frequencies of 19 The open space square means the 5Ј-or 3Ј-untranslated regions and the dotted space square means the open reading frame in the genomic structure on the top of this figure. The exon 15 including the novel polymorphism is shown below this genomic structure. There were eight haplotypes; the repeat number of the VNTR and the G2319A polymorphism is shown on the left of this figure. PCR primers are shown under the scheme of G6 by arrowheads. In haplotype analysis, PCR with 3Ј-UTR-F and 3Ј-UTR-R was performed (see Materials and methods for details). G2319A polymorphism is distinguished with Msp I restriction enzyme. VNTR, Variable number of tandem repeat. the G2319A-polymorphism in controls, alcoholics and schizophrenics were shown in Table 1 . In genotypic frequencies, there was a significant association between the G2319A-polymorphism and alcoholics (P = 0.040). In allelic frequencies, a significant increase in the 2319-A allele prevalence was observed in alcoholic patients (P = 0.019). Odds ratio (OR) for alcoholism with the 2319-A allele was 1.73 (1.11-2.72, Fisher's P = 0.019). The risk for alcoholic dependency was increased by its presence. There was a significant dose effect for the risk associated with th 2319-A allele for alcoholism as assessed by the linearity tendency test ( 2 = 6.16, df = 2, P = 0.046; Cochranq-Armitage analysis). There were no significant differences between controls and schizophrenic patients in both genotypic and allelic frequencies of the G2319A-polymorphism.
The 2319-A was found only in the 10-, 11-, and 14-repeat alleles of the VNTR polymorphism of the DAT1 gene. All of the 14-repeat VNTR alleles possessed 2319-A ( Table 2 ). The G2319A polymorphism showed a significant linkage disequilibrium with VNTR polymorphism ( 2 = 14.24, df = 5, P = 0.014). Codominant Table 2 Genotypic and allelic frequencies in haplotype of the DAT1 gene with both the novel G2319A and VNTR polymorphisms among controls, alcoholic patients, and schizophrenic patients. The frequencies in proportion (%) are shown in (a). Distributions (frequency with proportion, %, in parentheses) of haplotypes compared to either A10 or G10 allele among controls, alcoholic patients, and schizophrenic patients are shown in (b) and (c) segregation of the alleles was observed in a two-generation family (data not shown). In the haplotype analysis with the G2319A-and VNTR-polymorphisms, there was a significant association in allelic frequencies between controls and alcoholics (P = 0.014, extended Fisher's exact test, Table 2 ). Odds ratio (OR) for alcoholism with the A10 allele was 1.76 (1.12-2.76).
(a) Haplotype analysis
There was a significant positive gene dose effect for the risk for alcoholism associated with the A10 allele as assessed by the linearity tendency test ( 2 = 6.26, df = 2, P = 0.044; Cochranq-Armitage analysis). In contrast, the risk was significantly decreased when harboring G10 allele (odds ratio with the G10 allele, 0.53 (0.32-0.79), P = 0.002; Fisher's exact test), and there was a negative gene dose effect with this haplotype ( 2 = 9.13, df = 2, P = 0.010; Cochranq-Armitage analysis).
Discussion
Since the discovery of the VNTR polymorphism in the 3Ј-UTR region of the DAT1 gene, many studies have been performed to examine the association between the VNTR polymorphism and neuropsychiatric disorders. Some of the studies showed positive results with attention-deficit disorders, 21 alcoholic patients with low activity of aldehyde dehydrogenase, 13 and alcoholic patients with delirium or epileptic episode.
14 Others reported no association between DAT1 and substance abuse. 15 The most likely explanation for their minimal significant difference is undetected population stratification. In this study, we found a novel polymorphic site in the 3Ј-UTR region of the DAT1 gene and found a significant association between the G2319A polymorphism and alcoholics compared with control subjects (Table 1) , in which higher frequency of the 2319-A allele in the alcoholic patient group was observed. Our haplotype analysis with this G2319A polymorphism combined with the VNTR polymorphism (Table 2 ) demonstrated a significant association of the DAT1 gene and alcoholism. The A10 allele showed a significantly higher frequency in alcoholic subjects and its positive dose effect was found. On the other hand, the G10 allele showed a significantly lower frequency and a negative dose effect in alcoholism. In this study there was a marked disequilibrium in the sex ratio between controls and the alcoholic subjects studied. The DAT1 gene is located on human chromosome 5p15.3, an autosome, 22 indicating no gender effect in its expression. Actually, we could also demonstrate a significant association between male controls and male alcoholics with both the A10 haplotype and the G10 haplotype in genotypic and allelic frequencies (P = 0.046 and 0.023 in A10, 0.043 and 0.012 in G10, respectively; Fisher's exact test). Muramatsu et al reported the frequency of the 7-repeat allele in the VNTR polymorphism of the DAT1 gene was significantly higher in alcoholics with aldehyde dehydrogenase-II*2 (deficiency type), 13 but we could not repeat the result.
It is unclear how the A10 allele acts as a risk factor for alcoholism because these polymorphic sites lie outside the translated region of the DAT1 gene. These polymorphisms may be linked to other functional polymorphisms in the DAT1 gene, for example, the promoter site, a point or deletion mutation of the open reading frame or even an intron. The dose effect of the 2319-A allele and the haplotype found in alcoholics indicates that the polymorphism in the 3Ј-UTR itself affects its function such as the effect on its translational activity. The functional correlation between the G2319A polymorphism and the 10-repeat of the VNTR polymorphism to vulnerability of alcoholism is also interesting. Further study is needed.
The reuptake system of dopamine by DAT1 is believed to be the primary mechanism for termination of dopaminergic neurotransmission. Psychostimulants, such as cocaine and methamphetamine, are known to bind primarily to DAT1 and increase the synaptic dopamine level. 23, 24 The DAT1 gene seems to be critically involved in maitaining the delicate balance of the dopaminergic system and its changes of expression will affect the brain's capacity for long-term effects of ethanol on cerebral function. DAT1 gene variants do not appear to provide widespread contributions to the etiology of schizophrenia spectrum disorders, according to linkage studies. 18, 25 Most of the previous studies on the VNTR polymorphism of the DAT1 gene showed no positive evidence of allelic association between DAT1 alleles and schizophrenia, however, one of the studies showed that the DAT1 genotype distribution in schizophrenic patients did display a statistically significant departure from the genotype distribution found in controls. 26 There was no significant difference between controls and schizophrenic patients in the present study in both allelic and genotypic distributions of the novel polymorphism of the DAT1 gene, nor in the haplotype analysis. In conclusion, although further investigations are needed to clarify the real functional significance, the association between the DAT1 gene and alcoholic disorder was demonstrated using the polymorphism newly identified in the 3Ј-UTR of the DAT1 gene.
